Document is current

Article History

Received: 7 July 2022

Accepted: 28 December 2022

First Online: 9 January 2023

Declarations

: The views expressed here are those of the authors and do not necessarily represent the views of the American College of Rheumatology (ACR), the European Alliance of Associations for Rheumatology (EULAR), and the (UK) National Health Service (NHS), the National Institute for Health Research (NIHR) or the (UK) Department of Health.

: Irish National Research Ethics Committee for COVID-19 (20-NREC-COV-010).

: Richard Conway: speakers bureau Janssen, Roche, Sanofi, Abbvie, Clinical Trials: Abbvie, grant/research support: Janssen; Elena Nikiphorou: speakers bureau: AbbVie, Eli-Lilly, Gilead, Celltrion, Pfizer, Sanofi, Fresenius, grant/research support: Pfizer, Lilly; Christiana Demetriou: none declared; Candice Low: none declared; Kelly Leamy: none declared; John Ryan: none declared; Ronan Kavanagh: none declared; Alexander Fraser: none declared; John Carey: none declared; Paul O'Connell: none declared; Rachael Flood: none declared; Ronan Mullan: none declared; David Kane: none declared; Nicola Ambrose: none declared; Frances Stafford: none declared; Philip Robinson speakers bureau: UCB, Roche, Pfizer, Gilead, Janssen, Novartis; Eli Lilly, Abbvie, grant/research support from: Abbvie, UCB, Novartis, Janssen, Pfizer; Jean Liew: grant/research support from: Pfizer. Rebecca Grainger: speakers bureau: Pfizer, Cornerstones, Janssen, Novartis; Abbvie; Geraldine McCarthy: none declared.